Showing results (1761-1770 of 1,980) with videos related to
Sort By:
Pageof 198
American Journal of Preventive Medicine|January 18, 2011
Using the Clinical Prevention and Population Health Curriculum Framework to encourage curricular changeRika Maeshiro, Clyde H Evans, Joan M Stanley, et al.ACS Applied Materials & Interfaces|April 23, 2016
Correlating Lithium Hydroxyl Accumulation with Capacity Retention in V2O5 Aerogel CathodesLinda W Wangoh, Yiqing Huang, Ryan L Jezorek, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|February 22, 2005
Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancerMichael J Morris, Carlos Cordon-Cardo, William K Kelly, et al.Molecular and Cellular Endocrinology|December 22, 2015
Biological activity and in vivo half-life of pro-activin A in male ratsKatharine E Johnson, Yogeshwar Makanji, Peter Temple-Smith, et al.Urology|April 1, 1997
Assessment of hormone refractory prostate cancerD Newling, S D Fosså, L Andersson, et al.Vaccine|August 25, 2024
Patterns and predictors of COVID-19 vaccination among young adults at 44 US sites: Secondary analysis of a randomized, controlled, open-label trial, March - December 2021Nadja A Vielot, Nicole K Kelly, Christina Ludema, et al.Transfusion|August 5, 2022
Hormones, age, and sex affect platelet responsiveness in vitroJamie B Hadley, Marguerite R Kelher, Julia R Coleman, et al.Surgical Neurology International|June 8, 2022
Myeloid sarcoma of the skull base: A case report and systematic literature reviewPrazwal Athukuri, A Basit Khan, Ron Gadot, et al.European Journal of Cancer (Oxford, England : 1990)|April 5, 2011
An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumoursRebecca K Kelly, Dian L Olson, Yaping Sun, et al.Cell|December 14, 2011
Polycomb-repressed genes have permissive enhancers that initiate reprogrammingPhillippa C Taberlay, Theresa K Kelly, Chun-Chi Liu, et al.Pageof 198